楚江新材(002171.SZ):碳化鉭產業化項目已建成投產,高純碳粉已實現小批量生產
格隆匯8月13日丨有投資者向楚江新材(002171.SZ)提問,“公司的研發好像都很慢,高純碳粉研發了快5年還在中試,天鳥與主機廠合作研發剎車快一年了還是在研發,公司對於研發進度有啥管控措施嗎?”
楚江新材回覆稱,高純碳粉和碳陶剎車盤分別是子公司頂立科技和蕪湖天鳥的重點產品。頂立科技在相關材料與裝備方面圍繞“四高兩塗一裝備”的技術和產品佈局,其中碳化鉭產業化項目已建成投產,高純碳粉已實現小批量生產,公司會加快推進其技術工業化和產業化進程;蕪湖天鳥碳陶剎車盤使用江蘇天鳥的預製體,主要面向新能源汽車領域,公司會加快推進產品批量生產的進程。具體進展情況請關注公司在指定媒體披露的相關信息。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.